article thumbnail

Cap on Out-of-Pocket Insulin Costs in Inflation Reduction Act Increased Prescription Fills

Pharmacy Times

Thousands more people filled their insulin prescriptions following the introduction of the cap in January 2023, especially compared to those who were not enrolled in Medicare, a new study finds.

article thumbnail

Medicare Part D Claims Have Increased, But 340B Prescriptions Increased Faster

Pharmacy Times

The proportion of prescriptions by a 340B-affiliated physician increased from 9.4% in 2020, but the prescriptions filled by 340B pharmacies increased from 18.4% in 2013 to 19.3% to 49.9%.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Giving Priority to Patient Care in Neighborhood Pharmacies


This challenge is particularly prevalent in independent community pharmacies, where owners and managers juggle various roles, from prescription filling to team management and clinical services provision.

article thumbnail

Generic and Biosimilar Drugs Save $408B For America’s Patients and Healthcare System in 2022

Big Molecule Watch

According to the findings, more than 90% of all prescriptions filled in 2022 were for generic or biosimilar drugs, despite these medications accounting for less than 18% of the total prescription drug expenditure and a mere 2% of the overall U.S. Notably, the U.S. healthcare spending.

article thumbnail

STAT+: Health care CEOs hauled in $4 billion last year as inflation pinched workers, analysis shows


But health care stocks fell significantly less than other companies as the amount of care received and prescriptions filled returned closer to pre-pandemic norms. By almost every measure, 2022 was a bad year for the stock market.

article thumbnail

Revolutionizing Health Care: The Evolving Path of E-Prescriptions

National Association of Boards of Pharmacy

Further, a lack of interoperability between pharmacy systems can prevent electronic data sharing between competing pharmacies, which can be frustrating for patients, prescribers, and pharmacy staff when prescriptions are sent to the wrong pharmacy or the patient decides to have the prescription filled elsewhere.

article thumbnail

Which TPAs Are The Best At Optimizing 340B Savings And Revenue?

Proxsys Rx

340B program support fee structures In general, you should avoid TPAs that charge fees for every pharmacy prescription fill they assess. Even with a per-prescription fee as low as 24¢, your health system could be paying enormous 340B program process fees. Maximizing) 340B prescription matching comes into play.